In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates

被引：45

作者：

Kim, Dae Hun ^{[1
]}

Jhun, Byung Woo ^{[1
]}

Moon, Seong Mi ^{[1
]}

Kim, Su-Young ^{[1
]}

Jeon, Kyeongman ^{[1
]}

Kwon, O. Jung ^{[1
]}

Huh, Hee Jae ^{[2
]}

Lee, Nam Yong ^{[2
]}

Shin, Sung Jae ^{[3
,4
,5
]}

Daley, Charles L. ^{[6
,7
]}

Koh, Won-Jung ^{[1
]}

机构：

[1] Sungkyunkwan Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med,Samsung Med Ctr, Seoul, South Korea

[2] Sungkyunkwan Univ, Sch Med, Dept Lab Med & Genet, Samsung Med Ctr, Seoul, South Korea

[3] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea

[4] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea

[5] Yonsei Univ, Coll Med, Brain Korea 21 PLUS Project Med Sci, Seoul, South Korea

[6] Natl Jewish Hlth, Div Mycobacterial & Resp Infect, Denver, CO USA

[7] Univ Colorado, Dept Med, Aurora, CO USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2019年 / 63卷 / 08期

基金：

新加坡国家研究基金会;

关键词：

Mycobacterium abscessus; Mycobacterium avium complex; Mycobacteriurn kansasii; bedaquiline; delamanid; nontuberculous mycobacteria; TREATMENT OUTCOMES; PULMONARY-DISEASE; DIAGNOSIS; EMERGENCE; MECHANISM; DRUG;

D O I：

10.1128/AAC.00665-19

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We evaluated the in vitro activities of the antimicrobial drugs bedaquiline and delamanid against the major pathogenic nontuberculous mycobacteria (NTM). Delamanid showed high MIC values for all NTM except Mycobacterium kansasii. However, bedaquiline showed low MIC values for the major pathogenic NTM, including Mycobacterium avium complex, Mycobacterium abscessus subsp. abscessus, M. abscessus subsp. massiliense, and M. kansasii. Bedaquiline also had low MIC values with macrolide-resistant NTM strains and warrants further investigation as a potential antibiotic for NTM treatment.

引用

页数：6

共 50 条

[21] Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan
Matsuoka, M
Narita, M
Okazaki, N
Ohya, H
Yamazaki, T
Ouchi, K
Suzuki, I
Andoh, T
Kenri, T
Sasaki, Y
Horino, A
Shintani, M
Arakawa, Y
Sasaki, T
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4624 - 4630
[22] Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae:: Results of two years of the PROTEKT surveillance study
Schito, GC
Marchese, A
Elkharrat, D
Farrell, DJ
JOURNAL OF CHEMOTHERAPY, 2004, 16 (01) : 13 - 22
[23] PAAG15A REMOVES BIOFILMS AGAINST NONTUBERCULOUS MYCOBACTERIA CLINICAL ISOLATES
Townsend, S.
Narayanaswamy, V
Baker, S.
Wiesmann, W.
PEDIATRIC PULMONOLOGY, 2016, 51 : 339 - 340
[24] Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae
Walsh, F
Carnegy, F
Willcock, J
Amyes, S
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) : 793 - 796
[25] In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China
Luo, Jingjing
Yu, Xia
Jian, Guanglu
Fu, Yuhong
Huo, Fengmin
Ma, Yifeng
Wang, Fen
Shang, Yuanyuan
Liang, Qian
Xue, Yi
Huang, Hairong
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (07)
[26] Letter to the Editor: In Vitro Activity of Oxazolidinone Against Nontuberculous Mycobacteria in China
Zheng, Huiwen
Wang, Yiting
He, Wencong
Li, Feina
Xia, Hui
Xiao, Jing
Ou, Xichao
Wang, Shengfen
Shen, Chen
Zhao, Yanlin
MICROBIAL DRUG RESISTANCE, 2023, 29 (03) : 112 - 114
[27] Molecular characterisation of Hungarian macrolide-resistant Streptococcus pneumoniae isolates, including three highly resistant strains with the mef gene
Dobay, O
Rozgonyi, F
Amyes, SGB
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (06) : 488 - 495
[28] Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia
Morozumi, Miyuki
Takahashi, Takashi
Ubukata, Kimiko
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2010, 16 (02) : 78 - 86
[29] Antimicrobial Activity of Solithromycin against Serotyped Macrolide-Resistant Streptococcus pneumoniae Isolates Collected from US Medical Centers in 2012
Farrell, D. J.
Mendes, R. E.
Jones, R. N.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (04) : 2432 - 2434
[30] In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease
Kim, Dae Hun
Kim, Bo-Guen
Kim, Su-Young
Huh, Hee Jae
Lee, Nam Yong
Koh, Won-Jung
Kim, Hojoong
Kwon, O. Jung
Jhun, Byung Woo
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)

← 1 2 3 4 5 →